Company / EPS (Diluted)
Progyny EPS (Diluted) History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.62
FY2025
5-year range
$0.30 / $0.66
FY2021-FY2025
Trend
+106.7%
vs FY2024
Sector context
#80 of 159
Health Care
What the data says
At $0.62, Progyny's eps (diluted) ranks #80 of 159 in the Health Care sector. EPS (Diluted) has fluctuated over the past 9 years, ranging from $-2.37 in FY2017 to $0.66 in FY2023.
Based on SEC 10-K filings.
0.62 in FY2025 with a 5-year CAGR of +5.7%.
Declined from $0.66 to $0.62 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +9.7%
- 5-Year CAGR
- +5.7%
- 10-Year CAGR
- -
Sector benchmark
#80 of 159 in Health CareTop 50% of 159This company $0.62 Sector average $1.66
▼
-62.5% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 106.7% year-over-year.
- Ranks #80 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2023.
- Lowest eps (diluted) in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 3.62 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.62 | +106.7% |
| FY2024 | $0.30 | -54.5% |
| FY2023 | $0.66 | +40.4% |
| FY2022 | $0.47 | -28.8% |
| FY2021 | $0.66 | +40.4% |
| FY2020 | $0.47 | +214.6% |
| FY2019 | -$0.41 | -1125.0% |
| FY2018 | $0.04 | +101.7% |
| FY2017 | -$2.37 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026